Chlamydia Vaccine (Recombinant) from Canada
Recombinant chlamydial major outer membrane protein vaccine for trachoma and STD prevention. Classified under HTS 3002.49.00 as 'other' immunological products from biotech processes. Adjuvanted formulation.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Provide recombinant protein purity certificates
• Avoid diagnostic reagent misclassification
• Document adjuvant compatibility for stability